Stoke Therapeutics (STOK) P/E (2019 - 2026)
Stoke Therapeutics (STOK) P/E from Jul 1, 2019 to Jul 21, 2026. The TTM Stoke Therapeutics (STOK) P/E is -9.90. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Stoke Therapeutics (STOK)
| Year | P/E | Change |
|---|---|---|
| 2026 | -9.90 | -98.74% |
| 2025 | -785.18 | +12367.94% |
| 2024 | -6.30 | +188.30% |
| 2023 | -2.18 | -38.89% |
| 2022 | -3.57 | -65.24% |
| 2021 | -10.28 | -74.54% |
| 2020 | -40.39 | +15.72% |
| 2019 | -34.91 | N/A |
Comparison Stoke Therapeutics (STOK) P/E with competitors
Stoke Therapeutics (STOK) P/E is -9.90.